Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Dose of Intravenous Oxycodone for Attenuation of Hemodynamic

NCT02484352 is registered in ClinicalTrials.gov with Yong-Hee Park as lead sponsor.

NCT NCT02484352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02484352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Dose of Intravenous Oxycodone for Attenuation of Hemodynamic
Lead sponsor
Yong-Hee Park
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2015
Completion date
February 12, 2017
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, intubation complication